Syros Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €8.51M -33.2% -€140.89M +233.8% -1,656.3% -13 pp -€93.69M -10.2% -1,101.4% -2.8 pp
    €12.74M -36.6% -€42.21M -45.5% -331.3% +0.54 pp -€104.29M +23.9% -818.7% -4.0 pp
    €20.11M +55.6% -€77.45M +5.4% -385.2% +1.8 pp -€84.15M +81.9% -418.5% -0.61 pp
    €12.92M +661.5% -€73.48M +13.8% -568.7% +32 pp -€46.25M +13.5% -358.0% +20 pp
    €1.70M -3.3% -€64.58M +21.1% -3,806.2% -7.7 pp -€40.76M +22.3% -2,402.4% -5.0 pp
    €1.75M +86.2% -€53.32M +15.3% -3,038.0% +19 pp -€33.33M -11.3% -1,899.1% +21 pp
    €942.56K +247.3% -€46.24M +13.1% -4,905.5% +100 pp -€37.59M +14.9% -3,988.0% +81 pp
    €271.38K +0.0% -€40.87M +60.1% -15,060.9% -57 pp -€32.71M +74.9% -12,054.9% -52 pp
    €271.38K +∞% -€25.53M +122.0% -9,406.3% -94 pp -€18.71M +85.7% -6,894.0% -69 pp
    €0.00 +NaN% -€11.50M +45.1% N/A -€10.07M +86.3% N/A
    €0.00 -€7.93M N/A -€5.41M N/A

    Notifications